MOSCOW (MRC) -- Evonik Industries announced it has concluded a purchase agreement to take over the start-up Alkion Biopharma SAS, headquartered in Evry, France. Alkion Biopharma SAS is a leading manufacturer of biotechnologically developed cosmetic active ingredients, said the producer on its site.
The company has developed methods for cultivating plant biomass under laboratory conditions.
Evonik said the company is purchasing Alkion to expand the portfolio of the Personal Care Business Line in the area of active ingredients.
As MRC informed earlier, Air Products is in advanced talks to sell its performance materials operations to Evonik Industries. The business, which makes chemicals used in sun lotion and paint, could be valued at more than USD3.5 billion.
Alkion Biopharma SAS is one of the leading manufacturers of biotechnologically developed cosmetic active ingredients. The company has developed methods for cultivating plant biomass under laboratory conditions and obtaining extracts from this with an exceptionally high yield of complex ingredients.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around EUR13.5 billion and an operating profit (adjusted EBITDA) of about EUR2.47 billion.
MRC